Back

EDEN

-5.29%
NEUTRAL

Eden Research Directors Increase Shareholdings

Why we think this is neutral

This RNS announcement is a standard regulatory update on director share purchases, which does not contain any material financial information or updates on the company's operations, performance, or outlook. As such, it is likely to have a neutral impact on market sentiment.

Key Points

  • CEO Sean Smith purchased 329,041 shares
  • CFO Alex Abrey purchased 167,947 shares

Summary

The agricultural inputs company announces its directors have purchased additional shares.

Eden Research plc, a leader in sustainable biopesticide and biocontrol technology, has announced that its Chief Executive Officer and Chief Financial Officer have purchased additional ordinary shares in the company. The purchases were made at a volume-weighted average price of 3.02 pence per share.

DIRECTOR DEALINGS